Abstract
The appropriate management of patients with ovarian cancer requires a thorough primary surgical staging, and a subsequent surgical evaluation of response to therapy is often indicated. In most patients, even those whose tumors have disseminated throughout the peritoneal cavity, the extent of disease prior to initiation of therapy is unclear because the metastases are asymptomatic. In addition, since the majority of individuals are in clinical remission at the completion of their chemotherapy, an operative method is needed to assess the response to therapy, because noninvasive techniques are too insensitive. The ‘second-look’ operation has become a standard procedure in many institutions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Day TG, Smith JP: Diagnosis and staging of ovarian cancer. Semin Oncol 2:217, 1975.
Scully RE: Tumors of the ovary and maldeveloped gonads. AFIP Fascicle 16, Washington D.C., 1979.
Plentl AA, Friedman EA: Lymphatic system of the female genitalia. W.B. Saunders Co., Philadelphia, 1971.
Fisher R, Young R: Advances in the staging and treatment of ovarian cancer. Cancer 39:967, 1977.
Hreschchyshyn MM, Park RC, Blessing JA, Norris HJ, Levy D, Lagasse LD, Creasman WT: The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 138:139, 1980.
Piver MS, Barlow JJ, Lele SB: Incidence of subclinical metastasis in Stage I and II ovarian carcinoma. Obstet Gynecol 52:100, 1978.
Creasman WT, Rutledge F: The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 110:773, 1971.
Keettel WC, Pixley EE, Buchsbaum HJ: Experience with peritoneal cytology in the management of gynecologic malignancies. Am J Obstet Gynecol 120:174, 1974.
Delgado G, Chun B, Caglar H: Paraaortic lymphadenectomy in gynecologic malignancies confined to the pelvis. Obstet Gynecol 50:418, 1977.
Morton DG, Moore JG, Chang N: The clinical value of peritoneal lavage for cytologic evaluation. Am J Obstet Gynecol 81:1115, 1961.
Buchsbaum H, Delgado G, Miller A: Surgical staging of ovarian cancer. Gynecologic Oncology Group: Statistical Report. Denver, CO, July 1983, pp 27–28.
Knapp RC, Friedman EA: Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol 119:1013–1017, 1974.
Rosenoff SH, DeVita VT Jr, Hubbard S, et al.: Peritoneoscopy in the staging and followup of ovarian cancer. Semin Oncol 2:223, 1975.
Musumeci R, DePalo G, Kenda R. et al.: Retroperitoneal metastases from ovarian carcinoma: Reasessment of 365 patients studied with lymphography. Am J Radiol 134:449–452, 1980.
Berek JS, Hacker NF: Laparoscopy in the management of patients with ovarian carcinoma, in The Treatment of Ovarian Cancer, edited by DiSaia P, Chapter 4, W.B. Saunders, london, August, 10(2):213–222, 1983.
Bagley CM, Young RC, Schien PS, Chabner BA, DeVita VT: Ovarian cancer metastatic to the diaphragm frequently undiagnosed at laparotomy. A preliminary report. Am J Obstet Gynecol 116:397–404, 1973.
Rosenoff SH, Young RC, Anderson T, et al.: Peritoneoscopy: a valuable staging tool in ovarian carcinoma. Ann Int Med 83:37–41, 1975.
Spinelli P, Luini A, Pizzetti P, DePalo GM: Laparoscopy in staging and restaging of 95 patients with ovarian carcinoma. Tumori 62:493–502, 1976.
Piver MS, Lopez RG, Xynos F, et al.: The value of pre-therapy peritoneoscopy in localized ovarian cancer. Am J Obstet Gynecol 127:288, 1977.
Mangioni C, Bolis G, Molteni P, Belloni C: Indications, advantages and limitations of laparoscopy in ovarian cancer. Gyn Oncol 7:47–55, 1979.
Ozols RF, Fisher RI, Anderson T, Makuch R, Young RC: Peritoneoscopy in the management of ovarian cancer. Am J obstet Gynecol 140:611–619, 1981.
Berek JS, Griffiths CT, Leventhal JM: Laparoscopy of second-look evaluation in ovarian cancer. Obstet Gynecol 58:192–198, 1981.
Hassan HM: A modified instrument and method for laparoscopy. Am J Obstet Gynecol 110:886–889, 1971.
Griffiths CT: Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl CA Institute Monograph 42:101–104, 1975.
Griffiths CT, Fuller AF: Intensive surgical management of advanced ovarian cancer. Surg Clinic No Amer 58:131–143, 1978.
Hacker NF, Berek JS, Lagasse LD, et al.: Primary cytoreductive surgery in ovarian cancer. Obstet Gynecol 61:413–420, 1983.
Schwartz PE, Smith JP: Second-look operation in ovarian cancer. Am J Obstet Gynecol 138:1124, 1980.
Smith JP, Delgado G, Rutledge F: Second-look operation in ovarian cancer. Cancer 38:1438, 1976.
Phillips BD, Buchsbaum HJ, Lifshitz S: Re-exploration after treatment for ovarian carcinoma. Gynecol Oncol 8:339, 1979.
Curry SL, Zembo MM, Nahhas WA, et al.: Second-look laparotomy for ovarian cancer. Gynecol Oncol 11:114, 1981.
Webb MJ, Snyder JA, Williams TJ, et al.: Second-look laparotomy in ovarian cancer. Gynecol Oncol 14:285, 1982.
Raju KS, McKinna JA, Barker GH, et al.: Second-look operations in the planned management of advanced ovarian carcinoma. Am J Obstet Gynecol 144:650, 1982.
Roberts WS, Hodel K, Rich WM, et al.: Second-look laparotomy in the management of gynecologic malignancy. Gynecol Oncol 13:345, 1982.
Gershenson DM, Copeland CJ, Wharton JT, et al.: Surgically-determined complete responders in advanced ovarian cancer. Proc Soc Gyn Onc 14:18, Marco Island, FL, 1983.
Berek JS, Hacker NF, Lagasse LD, et al.: Second-look laparotomy in Stage III epithelial ovarian cancer: clinical variables associated with disease status. Obstet Gynecol 64:207–212, 1984.
Berek JS, Hacker NF, Lagasse LD, et al.: Survival of patients with ovarian cancer following secondary cytoreductive surgery. Obstet Gynecol 61:189–193, 1983.
Young RC, Chabner BA, Hubbard SP, et al.: Advanced ovarian adenocarcinoma: a prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 299:1261, 1978.
Kapadia SB, Krause JR: Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy. Cancer 41:1670–1680, 1978.
Reimer RA, Hoover R, Fraumeni JF, Young RC: Acute leukemia alkylating agent therapy of ovarian cancer. N Eng J Med 297:177–181, 1977.
Piver MS, Lele SB, Barlow JJ, Gamarra M: Second-look laparoscopy prior to proposed second-look laparotomy. Obstet Gynecol 55:571–573, 1980.
Lacey CG, Morrow CP, DiSaia PJ, Lucas WE: Laparoscopy in the evaluation of gynecologic cancer. Obstet Gynecol 52:708–712, 1978.
Smith WG, Day TG, Smith JP: The use of laparoscopy to determine the results of chemotherapy for ovarian cancer. J Rep Med 18:257–260, 1977.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Berek, J.S., Hacker, N.F. (1985). Staging and second-look operations in ovarian cancer. In: Alberts, D.S., Surwit, E.A. (eds) Ovarian Cancer. Cancer Treatment and Research, vol 23. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2561-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2561-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9609-6
Online ISBN: 978-1-4613-2561-1
eBook Packages: Springer Book Archive